4dmedical Stock Fundamentals
| 4DX Stock | 0.50 0.01 2.04% |
4Dmedical fundamentals help investors to digest information that contributes to 4Dmedical's financial success or failures. It also enables traders to predict the movement of 4Dmedical Stock. The fundamental analysis module provides a way to measure 4Dmedical's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to 4Dmedical stock.
At this time, 4Dmedical's Depreciation And Amortization is comparatively stable compared to the past year. Total Revenue is likely to gain to about 4.5 M in 2025, despite the fact that EBIT is likely to grow to (30.7 M). 4Dmedical | Select Account or Indicator |
4Dmedical Company Shares Outstanding Analysis
4Dmedical's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.
Current 4Dmedical Shares Outstanding | 413.6 M |
Most of 4Dmedical's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, 4Dmedical is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
| Competition |
4Dmedical Common Stock Shares Outstanding
Common Stock Shares Outstanding |
|
Based on the latest financial disclosure, 4Dmedical has 413.6 M of shares currently outstending. This is 129.1% higher than that of the Health Care Equipment & Supplies sector and 136.41% higher than that of the Health Care industry. The shares outstanding for all Australia stocks is 27.67% higher than that of the company.
4Dmedical Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining 4Dmedical's current stock value. Our valuation model uses many indicators to compare 4Dmedical value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across 4Dmedical competition to find correlations between indicators driving 4Dmedical's intrinsic value. More Info.4Dmedical is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the 4Dmedical's earnings, one of the primary drivers of an investment's value.4Dmedical Shares Outstanding Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses 4Dmedical's direct or indirect competition against its Shares Outstanding to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of 4Dmedical could also be used in its relative valuation, which is a method of valuing 4Dmedical by comparing valuation metrics of similar companies.4Dmedical is currently under evaluation in shares outstanding category among its peers.
4Dmedical Fundamentals
| Return On Equity | -0.51 | ||||
| Return On Asset | -0.27 | ||||
| Operating Margin | (7.55) % | ||||
| Current Valuation | 175.61 M | ||||
| Shares Outstanding | 413.6 M | ||||
| Shares Owned By Insiders | 21.94 % | ||||
| Shares Owned By Institutions | 5.63 % | ||||
| Price To Book | 2.86 X | ||||
| Price To Sales | 54.53 X | ||||
| Revenue | 3.75 M | ||||
| Gross Profit | 684.43 K | ||||
| EBITDA | (31.86 M) | ||||
| Net Income | (35.98 M) | ||||
| Total Debt | 5.12 M | ||||
| Book Value Per Share | 0.17 X | ||||
| Cash Flow From Operations | (30.87 M) | ||||
| Earnings Per Share | (0.10) X | ||||
| Target Price | 0.9 | ||||
| Number Of Employees | 145 | ||||
| Beta | 1.34 | ||||
| Market Capitalization | 204.73 M | ||||
| Total Asset | 120.02 M | ||||
| Retained Earnings | (152.04 M) | ||||
| Working Capital | 17.16 M | ||||
| Net Asset | 120.02 M |
About 4Dmedical Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze 4Dmedical's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of 4Dmedical using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of 4Dmedical based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.| Last Reported | Projected for Next Year | ||
| Current Deferred Revenue | 1.2 M | 1.1 M | |
| Total Revenue | 4.3 M | 4.5 M | |
| Cost Of Revenue | 213 K | 202.4 K |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for 4Dmedical Stock Analysis
When running 4Dmedical's price analysis, check to measure 4Dmedical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy 4Dmedical is operating at the current time. Most of 4Dmedical's value examination focuses on studying past and present price action to predict the probability of 4Dmedical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move 4Dmedical's price. Additionally, you may evaluate how the addition of 4Dmedical to your portfolios can decrease your overall portfolio volatility.